Title of article :
Nuisance Bleeding With Prolonged Dual Antiplatelet Therapy After Acute Myocardial Infarction and its Impact on Health Status
Author/Authors :
Amin، نويسنده , , Amit P. and Bachuwar، نويسنده , , Alok and Reid، نويسنده , , Kimberly J. and Chhatriwalla، نويسنده , , Adnan K. and Salisbury، نويسنده , , Adam C. and Yeh، نويسنده , , Robert W. and Kosiborod، نويسنده , , Mikhail and Wang، نويسنده , , Tracy Y. and Alexander، نويسنده , , Karen P. and Gosch، نويسنده , , Kensey and Cohen، نويسنده , , David J. and Spertus، نويسنده , , John A. and Bach، نويسنده , , Richard G.، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2013
Abstract :
Objectives
rpose of this study was to examine the incidence of nuisance bleeding after AMI and its impact on QOL.
ound
ged dual antiplatelet therapy (DAPT) is recommended after acute myocardial infarction (AMI) to reduce ischemic events, but it is associated with increased rates of major and minor bleeding. The incidence of even lesser degrees of post-discharge “nuisance” bleeding with DAPT and its impact on quality of life (QOL) are unknown.
s
rom the 24-center TRIUMPH (Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patientsʹ Health Status) study of 3,560 patients, who were interviewed at 1, 6, and 12 months after AMI, were used to investigate the incidence of nuisance bleeding (defined as Bleeding Academic Research Consortium type 1). Baseline characteristics associated with “nuisance” bleeding and its association with QOL, as measured by the EuroQol 5 Dimension visual analog scale, and subsequent re-hospitalization were examined.
s
ce (Bleeding Academic Research Consortium type 1) bleeding occurred in 1,335 patients (37.5%) over the 12 months after AMI. After adjusting for baseline bleeding and mortality risk, ongoing DAPT was the strongest predictor of nuisance bleeding (rate ratio [RR]: 1.44, 95% confidence interval [CI]: 1.17 to 1.76 at 1 month; RR: 1.89, 95% CI: 1.35 to 2.65 at 6 months; and RR: 1.39, 95% CI: 1.08 to 1.79 at 12 months; p < 0.01 for all comparisons). Nuisance bleeding at 1 month was independently associated with a decrement in QOL at 1 month (−2.81 points on EuroQol 5 Dimension visual analog scale; 95% CI: 1.09 to 5.64) and nonsignificantly toward higher re-hospitalization (hazard ratio: 1.20; 95% CI: 0.95 to 1.52).
sions
ce bleeding is common in the year after AMI, associated with ongoing use of DAPT, and independently associated with worse QOL. Improved selection of patients for prolonged DAPT may help minimize the incidence and adverse consequences of nuisance bleeding.
Keywords :
dual antiplatelet therapy , Clopidogrel , EuroQol , Quality of life , nuisance bleeding
Journal title :
JACC (Journal of the American College of Cardiology)
Journal title :
JACC (Journal of the American College of Cardiology)